Cargando…

Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of coronavirus disease 2019 (COVID‐19) and is capable of human‐to‐human transmission and rapid global spread. Thus, the establishment of high‐quality viral detection and quantification methods, and the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Kyoko, Asai, Satomi, Umezawa, Kazuo, Kakizoe, Hidehumi, Miyachi, Hayato, Morita, Masanobu, Akaike, Takaaki, Kuno, Hitoshi, Komatsu, Satoko, Watanabe, Takumi, Kawahara, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761427/
https://www.ncbi.nlm.nih.gov/pubmed/34837712
http://dx.doi.org/10.1002/jcla.24146
_version_ 1784633525013577728
author Hayashi, Kyoko
Asai, Satomi
Umezawa, Kazuo
Kakizoe, Hidehumi
Miyachi, Hayato
Morita, Masanobu
Akaike, Takaaki
Kuno, Hitoshi
Komatsu, Satoko
Watanabe, Takumi
Kawahara, Toshio
author_facet Hayashi, Kyoko
Asai, Satomi
Umezawa, Kazuo
Kakizoe, Hidehumi
Miyachi, Hayato
Morita, Masanobu
Akaike, Takaaki
Kuno, Hitoshi
Komatsu, Satoko
Watanabe, Takumi
Kawahara, Toshio
author_sort Hayashi, Kyoko
collection PubMed
description BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of coronavirus disease 2019 (COVID‐19) and is capable of human‐to‐human transmission and rapid global spread. Thus, the establishment of high‐quality viral detection and quantification methods, and the development of anti‐SARS‐CoV‐2 agents are critical. METHODS: Here, we present the rapid detection of infectious SARS‐CoV‐2 particles using a plaque assay with 0.5% agarose‐ME (Medium Electroosmosis) as an overlay medium. RESULTS: The plaques were capable of detecting the virus within 36–40 h post‐infection. In addition, we showed that a monogalactosyl diacylglyceride isolated from a microalga (Coccomyxa sp. KJ) could inactivate the clinical isolates of SARS‐CoV‐2 in a time‐ and concentration‐dependent manner. CONCLUSIONS: These results would allow rapid quantification of the infectious virus titers and help develop more potent virucidal agents against SARS‐CoV‐2.
format Online
Article
Text
id pubmed-8761427
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87614272022-01-20 Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay Hayashi, Kyoko Asai, Satomi Umezawa, Kazuo Kakizoe, Hidehumi Miyachi, Hayato Morita, Masanobu Akaike, Takaaki Kuno, Hitoshi Komatsu, Satoko Watanabe, Takumi Kawahara, Toshio J Clin Lab Anal Research Articles BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causative agent of coronavirus disease 2019 (COVID‐19) and is capable of human‐to‐human transmission and rapid global spread. Thus, the establishment of high‐quality viral detection and quantification methods, and the development of anti‐SARS‐CoV‐2 agents are critical. METHODS: Here, we present the rapid detection of infectious SARS‐CoV‐2 particles using a plaque assay with 0.5% agarose‐ME (Medium Electroosmosis) as an overlay medium. RESULTS: The plaques were capable of detecting the virus within 36–40 h post‐infection. In addition, we showed that a monogalactosyl diacylglyceride isolated from a microalga (Coccomyxa sp. KJ) could inactivate the clinical isolates of SARS‐CoV‐2 in a time‐ and concentration‐dependent manner. CONCLUSIONS: These results would allow rapid quantification of the infectious virus titers and help develop more potent virucidal agents against SARS‐CoV‐2. John Wiley and Sons Inc. 2021-11-27 /pmc/articles/PMC8761427/ /pubmed/34837712 http://dx.doi.org/10.1002/jcla.24146 Text en © 2021 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Hayashi, Kyoko
Asai, Satomi
Umezawa, Kazuo
Kakizoe, Hidehumi
Miyachi, Hayato
Morita, Masanobu
Akaike, Takaaki
Kuno, Hitoshi
Komatsu, Satoko
Watanabe, Takumi
Kawahara, Toshio
Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay
title Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay
title_full Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay
title_fullStr Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay
title_full_unstemmed Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay
title_short Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS‐CoV‐2 as assessed by a plaque assay
title_sort virucidal effect of monogalactosyl diacylglyceride from a green microalga, coccomyxa sp. kj, against clinical isolates of sars‐cov‐2 as assessed by a plaque assay
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761427/
https://www.ncbi.nlm.nih.gov/pubmed/34837712
http://dx.doi.org/10.1002/jcla.24146
work_keys_str_mv AT hayashikyoko virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT asaisatomi virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT umezawakazuo virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT kakizoehidehumi virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT miyachihayato virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT moritamasanobu virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT akaiketakaaki virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT kunohitoshi virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT komatsusatoko virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT watanabetakumi virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay
AT kawaharatoshio virucidaleffectofmonogalactosyldiacylglyceridefromagreenmicroalgacoccomyxaspkjagainstclinicalisolatesofsarscov2asassessedbyaplaqueassay